BrightHeart secured 11 million Euro in Series A funding to scale its AI-driven prenatal ultrasound p...
The AMW Read
Updates the player map for vertical AI in healthcare with a successful Series A and validated clinical efficacy, though the funding amount does not trigger cross.§D.
NoveltySignificance
Healthcare & Bio · Player Map
BrightHeart secured 11 million Euro in Series A funding to scale its AI-driven prenatal ultrasound platform following five FDA clearances. Clinical data from Mount Sinai shows the technology boosts detection of major heart defects to over 97 percent, significantly addressing the 1 in 100 infants born with congenital heart defects. Beyond accuracy, the platform delivers an 18 percent reduction in reading time, providing critical relief for overstretched OB-GYNs. 🏥
